Published in J Am Soc Nephrol on May 06, 2010
Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection. PLoS Pathog (2011) 1.46
T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage. Biomed Res Int (2015) 1.41
Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage. J Am Soc Nephrol (2011) 1.33
Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells. Mediators Inflamm (2012) 1.00
AqF026 is a pharmacologic agonist of the water channel aquaporin-1. J Am Soc Nephrol (2013) 0.99
Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury. J Am Soc Nephrol (2014) 0.96
The Current State of Peritoneal Dialysis. J Am Soc Nephrol (2016) 0.90
Identification of a novel developmental mechanism in the generation of mesothelia. Development (2012) 0.90
Inhibition of transforming growth factor-activated kinase 1 (TAK1) blocks and reverses epithelial to mesenchymal transition of mesothelial cells. PLoS One (2012) 0.90
Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis. PLoS One (2013) 0.89
The Role of Mesothelial Cells in Liver Development, Injury, and Regeneration. Gut Liver (2016) 0.88
Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of Toll-like receptors. Nephrol Dial Transplant (2011) 0.87
Myofibroblastic Conversion and Regeneration of Mesothelial Cells in Peritoneal and Liver Fibrosis. Am J Pathol (2015) 0.87
Interstitial Fibrosis Restricts Osmotic Water Transport in Encapsulating Peritoneal Sclerosis. J Am Soc Nephrol (2015) 0.86
Thalidomide prevents the progression of peritoneal fibrosis in mice. Acta Histochem Cytochem (2011) 0.85
Transition of mesothelial cell to fibroblast in peritoneal dialysis: EMT, stem cell or bystander? Perit Dial Int (2015) 0.85
Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-β1/Smad3 signaling pathway in vitro. Int J Clin Exp Pathol (2015) 0.85
Mesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal Dialysis. Adv Med (2014) 0.85
Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis. Stem Cells Int (2016) 0.81
Effluent markers related to epithelial mesenchymal transition with adjusted values for effluent cancer antigen 125 in peritoneal dialysis patients. Int J Nephrol (2011) 0.81
Astragalus membranaceus inhibits peritoneal fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in rats submitted to peritoneal dialysis. Int J Mol Sci (2014) 0.80
Immune-Regulatory Molecule CD69 Controls Peritoneal Fibrosis. J Am Soc Nephrol (2016) 0.80
Animal Models of Peritoneal Dialysis: Thirty Years of Our Own Experience. Biomed Res Int (2015) 0.79
New Developments in Peritoneal Fibroblast Biology: Implications for Inflammation and Fibrosis in Peritoneal Dialysis. Biomed Res Int (2015) 0.79
A microrna screen to identify regulators of peritoneal fibrosis in a rat model of peritoneal dialysis. BMC Nephrol (2015) 0.79
A pathogenetic role for endothelin-1 in peritoneal dialysis-associated fibrosis. J Am Soc Nephrol (2014) 0.79
The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis. Stem Cells Transl Med (2015) 0.78
Morphological Retrospective Study of Peritoneal Biopsies from Patients with Encapsulating Peritoneal Sclerosis: Underestimated Role of Adipocytes as New Fibroblasts Lineage? Int J Nephrol (2015) 0.78
Membrane nanotubes between peritoneal mesothelial cells: functional connectivity and crucial participation during inflammatory reactions. Front Physiol (2014) 0.77
Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis. Inflammation (2015) 0.77
Regulation of chemokine CCL5 synthesis in human peritoneal fibroblasts: a key role of IFN-γ. Mediators Inflamm (2014) 0.77
Clinical application of right low-position modified peritoneal dialysis catheterization. Exp Ther Med (2012) 0.77
Adipose tissue behavior is distinctly regulated by neighboring cells and fluid flow stress: a possible role of adipose tissue in peritoneal fibrosis. J Artif Organs (2013) 0.77
Fluid dwell impact induces peritoneal fibrosis in the peritoneal cavity reconstructed in vitro. J Artif Organs (2015) 0.77
New insights into therapeutic strategies for the treatment of peritoneal fibrosis: learning from histochemical analyses of animal models. Acta Histochem Cytochem (2014) 0.76
Comparison of sirolimus and colchicine treatment on the development of peritoneal fibrozis in rats having peritoneal dialysis. Balkan Med J (2015) 0.76
Periostin: a matricellular protein involved in peritoneal injury during peritoneal dialysis. Perit Dial Int (2013) 0.76
Periostin-Binding DNA Aptamer Treatment Ameliorates Peritoneal Dialysis-Induced Peritoneal Fibrosis. Mol Ther Nucleic Acids (2017) 0.75
Genomic reprograming analysis of the Mesothelial to Mesenchymal Transition identifies biomarkers in peritoneal dialysis patients. Sci Rep (2017) 0.75
Bioincompatible impact of different peritoneal dialysis fluid components and therapeutic interventions as tested in a rat peritoneal dialysis model. Int J Nephrol (2011) 0.75
Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosis. PLoS One (2017) 0.75
Animal models in peritoneal dialysis. Front Physiol (2015) 0.75
A20 overexpression inhibits lipopolysaccharide-induced NF-κB activation, TRAF6 and CD40 expression in rat peritoneal mesothelial cells. Int J Mol Sci (2014) 0.75
Vascular Endothelial Cell Injury Is an Important Factor in the Development of Encapsulating Peritoneal Sclerosis in Long-Term Peritoneal Dialysis Patients. PLoS One (2016) 0.75
The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis. Cancers (Basel) (2015) 0.75
CD147 expression in peritoneal injury. Clin Exp Nephrol (2017) 0.75
Blocking Posttranslational Core Fucosylation Ameliorates Rat Peritoneal Mesothelial Cell Epithelial-Mesenchymal Transition. Chin Med J (Engl) (2017) 0.75
Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis. Sci Rep (2017) 0.75
Proinflammatory Effect of High Glucose Concentrations on HMrSV5 Cells via the Autocrine Effect of HMGB1. Front Physiol (2017) 0.75
Anti-fibrotic effects of valproic acid in experimental peritoneal fibrosis. PLoS One (2017) 0.75
Chondroitin sulfate prevents peritoneal fibrosis in mice by suppressing NF-κB activation. Med Mol Morphol (2016) 0.75
Apoptosis inhibitor of macrophage ameliorates fungus-induced peritoneal injury model in mice. Sci Rep (2017) 0.75
Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009) 4.41
Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol (2002) 3.33
Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J Immunol (2004) 2.95
Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling. Nat Med (2005) 2.06
Adenoviral gene transfer of connective tissue growth factor in the lung induces transient fibrosis. Am J Respir Crit Care Med (2003) 2.05
The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int (2004) 1.91
TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis. J Immunol (2005) 1.85
Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. J Rheumatol (2009) 1.84
Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J Clin Invest (2003) 1.69
IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. J Immunol (2008) 1.69
Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130. J Immunol (2003) 1.68
Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am J Respir Crit Care Med (2004) 1.66
IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. Proc Natl Acad Sci U S A (2005) 1.66
Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol (2006) 1.65
Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of "fibrosis-prone" and "fibrosis-resistant" mouse strains. Am J Respir Cell Mol Biol (2002) 1.61
The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl (2003) 1.58
Prolonged peritoneal gene expression using a helper-dependent adenovirus. Perit Dial Int (2009) 1.55
Vascular endothelial growth factor expression in peritoneal mesothelial cells undergoing transdifferentiation. Perit Dial Int (2008) 1.47
Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection. PLoS Pathog (2011) 1.46
Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling. J Biol Chem (2005) 1.45
12/15-Lipoxygenase regulates the inflammatory response to bacterial products in vivo. J Immunol (2008) 1.38
Loss of CD4+ T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells. J Immunol (2010) 1.36
TGF-beta1 induces progressive pleural scarring and subpleural fibrosis. J Immunol (2007) 1.36
A rapid crosstalk of human gammadelta T cells and monocytes drives the acute inflammation in bacterial infections. PLoS Pathog (2009) 1.35
Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis. J Immunol (2009) 1.35
Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trial. J Am Soc Nephrol (2002) 1.34
Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosis-resistant" BALB/c mouse lungs. Am J Respir Cell Mol Biol (2004) 1.31
Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering. J Immunol (2009) 1.22
Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival. J Am Soc Nephrol (2013) 1.18
Phosphatidylethanolamine-esterified eicosanoids in the mouse: tissue localization and inflammation-dependent formation in Th-2 disease. J Biol Chem (2009) 1.18
Smad3-dependent and -independent pathways are involved in peritoneal membrane injury. Kidney Int (2009) 1.15
Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms. J Immunol (2004) 1.14
The role of mouse strain differences in the susceptibility to fibrosis: a systematic review. Fibrogenesis Tissue Repair (2013) 1.13
Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1 but not TGF-beta3. Int J Biochem Cell Biol (2007) 1.11
Pathogen-specific local immune fingerprints diagnose bacterial infection in peritoneal dialysis patients. J Am Soc Nephrol (2013) 1.09
Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis. Arthritis Rheum (2006) 1.07
Estradiol increases extracellular levels of vascular endothelial growth factor in vivo in murine mammary cancer. Int J Cancer (2003) 1.04
Esterified eicosanoids are acutely generated by 5-lipoxygenase in primary human neutrophils and in human and murine infection. Blood (2010) 1.02
Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane. J Am Soc Nephrol (2003) 1.01
Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation. FASEB J (2010) 1.01
Enhanced neutrophil migratory activity following major blunt trauma. Injury (2005) 1.01
TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2. Eur J Immunol (2011) 1.00
Interferon-gamma protects against the development of structural damage in experimental arthritis by regulating polymorphonuclear neutrophil influx into diseased joints. Arthritis Rheum (2007) 0.98
Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration. Kidney Int (2003) 0.97
Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells. J Immunol (2002) 0.97
Sp1 and Sp3 mediate constitutive transcription of the human hyaluronan synthase 2 gene. J Biol Chem (2006) 0.96
Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int Suppl (2003) 0.96
Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Crit Care Med (2002) 0.95
TDAG51 mediates epithelial-to-mesenchymal transition in human proximal tubular epithelium. Am J Physiol Renal Physiol (2012) 0.95
Association between markers of inflammation, fibrosis and hypervolemia in peritoneal dialysis patients. Blood Purif (2009) 0.94
Functional effector memory T cells enrich the peritoneal cavity of patients treated with peritoneal dialysis. J Am Soc Nephrol (2009) 0.94
Glucose-mediated induction of TGF-beta 1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent. Kidney Int (2003) 0.93
Platelet derived growth factor B and epithelial mesenchymal transition of peritoneal mesothelial cells. Matrix Biol (2009) 0.92
Identification and analysis of the promoter region of the human hyaluronan synthase 2 gene. J Biol Chem (2004) 0.92
Intraperitoneal IL-6 signaling in incident patients treated with icodextrin and glucose bicarbonate/lactate-based peritoneal dialysis solutions. Perit Dial Int (2012) 0.91
Rapamycin inhibits transforming growth factor β-induced peritoneal angiogenesis by blocking the secondary hypoxic response. J Cell Mol Med (2012) 0.89
Temporal changes in MMP mRNA expression in the lens epithelium during anterior subcapsular cataract formation. Exp Eye Res (2008) 0.89
Interferon-gamma inhibits interleukin-1beta-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis. Arthritis Res Ther (2010) 0.88
Can artifact mimic the pathology of the peritoneal mesothelium? Perit Dial Int (2003) 0.88
Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of Toll-like receptors. Nephrol Dial Transplant (2011) 0.87
Waist-to-Hip Ratio, Cardiovascular Outcomes, and Death in Peritoneal Dialysis Patients. Int J Nephrol (2010) 0.87
Clinical indices of in vivo biocompatibility: the role of ex vivo cell function studies and effluent markers in peritoneal dialysis patients. Kidney Int Suppl (2003) 0.86
Morphological and functional changes in the dialysed peritoneal cavity: impact of more biocompatible solutions. Nephrol Dial Transplant (2002) 0.86
Viral IL-6 blocks neutrophil infiltration during acute inflammation. J Immunol (2005) 0.86
Oncostatin M receptor-beta signaling limits monocytic cell recruitment in acute inflammation. J Immunol (2008) 0.85
Management of hypophosphatemia in nocturnal hemodialysis with phosphate-containing enema: a technical study. Hemodial Int (2011) 0.84
The human hyaluronan synthase genes: genomic structures, proximal promoters and polymorphic microsatellite markers. Int J Biochem Cell Biol (2003) 0.84
Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients. BMC Nephrol (2014) 0.84
Peritoneal membrane transport: driving under the influence. Perit Dial Int (2006) 0.84
How can genetic advances impact on experimental models of encapsulating peritoneal sclerosis? Perit Dial Int (2008) 0.82
Estimated GFR reporting influences recommendations for dialysis initiation. J Am Soc Nephrol (2013) 0.82
Nitric oxide synthase isoforms play distinct roles during acute peritonitis. Nephrol Dial Transplant (2009) 0.82
Piece by piece: solving the puzzle of peritoneal fibrosis. Perit Dial Int (2008) 0.81
Differentiation of bone marrow-derived cells into regenerated mesothelial cells in peritoneal remodeling using a peritoneal fibrosis mouse model. J Artif Organs (2012) 0.80
Renal tubular angiogenic dysregulation in anti-Thy1.1 glomerulonephritis. Am J Physiol Renal Physiol (2010) 0.80
Twist: a new player in the epithelial-mesenchymal transition of the peritoneal mesothelial cells. Nephrol Dial Transplant (2012) 0.80
Neutrophil priming for elastase release in adult blunt trauma patients. J Trauma (2006) 0.80
Targeting the TLR co-receptor CD14 with TLR2-derived peptides modulates immune responses to pathogens. Sci Transl Med (2013) 0.79
Inhibition of nitric oxide synthase reverses permeability changes in a mouse model of acute peritonitis. Perit Dial Int (2005) 0.79
Adenovirus-mediated gene transfer of TGF-β1 to the renal glomeruli leads to proteinuria. Am J Pathol (2011) 0.79
Receptor-interacting protein-2 deficiency delays macrophage migration and increases intracellular infection during peritoneal dialysis-associated peritonitis. Am J Nephrol (2008) 0.78
Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function. J Am Soc Nephrol (2002) 0.78
Proteomics and peritoneal dialysis: early days but clear potential. Nephrol Dial Transplant (2010) 0.78
Switching on EMT in the peritoneal membrane: considering the evidence. Nephrol Dial Transplant (2010) 0.77
Transforming growth factor-beta and the glomerular filtration barrier. Kidney Res Clin Pract (2013) 0.77
Peritoneal morphological and functional changes associated with platelet-derived growth factor B. Nephrol Dial Transplant (2008) 0.77
Chemiluminescence: comparison of whole blood with isolated polymorphonuclear leukocytes after major trauma. J Trauma (2004) 0.77
Peritoneal dialysis-moving from current status to the future. Int J Nephrol (2013) 0.77
Peritoneal fibrosis is mouse strain dependent. Nephrol Dial Transplant (2012) 0.76
Adenovirus-based transient expression systems for peritoneal membrane research. Perit Dial Int (2006) 0.76
Association between N-terminal propeptide B-type natriuretic peptide and markers of hypervolemia. Perit Dial Int (2008) 0.76
Suppression of pro-inflammatory T-cell responses by human mesothelial cells. Nephrol Dial Transplant (2013) 0.76
Altering peritoneal membrane function: removing the GAG? Nephrol Dial Transplant (2009) 0.76
Now you see them, now you don't. Perit Dial Int (2004) 0.75
Neutrophil activation and renal scarring. Kidney Int (2005) 0.75
Encapsulating peritoneal sclerosis: time to act. Perit Dial Int (2006) 0.75
What are renal defensins defending? Nephron Exp Nephrol (2003) 0.75
Peritoneal infection and inflammation. Mediators Inflamm (2012) 0.75
The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid. Kidney Int Suppl (2003) 0.75